Cargando…
A comprehensive evaluation of clinical efficacy and safety of celecoxib in combination with chemotherapy in metastatic or postoperative recurrent gastric cancer patients: A preliminary, three-center, clinical trial study
AIM: To evaluate the efficacy and safety of celecoxib combined with chemotherapy in the treatment of metastatic or postoperative recurrent gastric cancer. METHODS: This preliminary, three-center, clinical trial study was conducted between September 2010 and December 2016. In the experimental group (...
Autores principales: | Guo, Qinghong, Li, Qiang, Wang, Jiong, Liu, Min, Wang, Yuping, Chen, Zhaofeng, Ye, Yuwei, Guan, Quanlin, Zhou, Yongning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635161/ https://www.ncbi.nlm.nih.gov/pubmed/31277138 http://dx.doi.org/10.1097/MD.0000000000016234 |
Ejemplares similares
-
Comprehensive evaluation of clinical efficacy and safety of celecoxib combined with chemotherapy in management of gastric cancer
por: Guo, Qinghong, et al.
Publicado: (2017) -
A novel circRNA, hsa_circ_0069382, regulates gastric cancer progression
por: Wang, Haoying, et al.
Publicado: (2023) -
Comprehensive analysis of gene regulation network and immune signatures of prognostic biomarker YAP1 in pancreatic cancer
por: Yang, Yuan, et al.
Publicado: (2020) -
Celecoxib as an adjuvant to chemotherapy for patients with metastatic colorectal cancer: A randomized controlled clinical study
por: Mostafa, Tarek M., et al.
Publicado: (2022) -
Association between bilirubin and nonalcoholic fatty liver disease in the non-obese Chinese population: a cross-sectional study
por: Shu, Xiaochuang, et al.
Publicado: (2022)